|
Résultats pour
brevets
1.
|
10
Numéro d'application |
CN2023096228 |
Numéro de publication |
2024/239309 |
Statut |
Délivré - en vigueur |
Date de dépôt |
2023-05-25 |
Date de publication |
2024-11-28 |
Propriétaire |
- KINGDOMWAY BIOTECHNOLOGY (JIANGSU) CO., LTD. (Chine)
- INNER MONGOLIA KINGDOMWAY PHARMACEUTICAL CO., LTD. (Chine)
- JIANGSU CHENGXIN PHARMACEUTICAL CO., LTD. (Chine)
- XIAMEN KINGDOMWAY GROUP COMPANY (Chine)
|
Inventeur(s) |
- Zhu, Jun
- Wang, Bingrong
- Xu, Fei
- Xing, Fei
- Li, Dan
|
Classes IPC ?
- C12P 23/00 - Préparation de composés contenant un cycle cyclohexène comportant une chaîne latérale non saturée d'au moins dix atomes de carbone liés par des doubles liaisons conjuguées, p. ex. carotènes
- C12N 9/02 - Oxydoréductases (1.), p. ex. luciférase
- C12N 15/70 - Vecteurs ou systèmes d'expression spécialement adaptés à E. coli
|
2.
|
GLYCERIC ACID, GLYCERATE, AND COMPOSITION THEREOF
Numéro d'application |
18594000 |
Statut |
En instance |
Date de dépôt |
2024-03-04 |
Date de la première publication |
2024-08-15 |
Propriétaire |
- INNER MONGOLIA KINGDOMWAY PHARMACEUTICAL CO., LTD. (Chine)
- XIAMEN KINGDOMWAY GROUP COMPANY (Chine)
- KINGDOMWAY BIOTECHNOLOGY (JIANGSU) CO., LTD. (Chine)
|
Inventeur(s) |
- Zhen, Ming
- Liu, Mengjing
- Wang, Li
- Liu, Qiyue
- Chen, Biqin
- Wang, Bingrong
- Li, Dan
- Wu, Yi
- Zhan, Guanghuang
|
Abrégé
The present disclosure provides a crystalline form of calcium D-glycerate of formula
The present disclosure provides a crystalline form of calcium D-glycerate of formula
The present disclosure provides a crystalline form of calcium D-glycerate of formula
and a method for preparing the crystalline form of calcium D-glycerate of formula (I). The crystalline form may be characterized by having X-ray powder diffraction pattern (XRPD) diffraction peaks (2θ degrees) at 12.9°±0.2°, 20.9°±0.2°, and 31.7°±0.2°.
|
3.
|
GLYCERIC ACID, GLYCERATE, AND COMPOSITION THEREOF
Numéro d'application |
CN2023106405 |
Numéro de publication |
2024/164494 |
Statut |
Délivré - en vigueur |
Date de dépôt |
2023-07-07 |
Date de publication |
2024-08-15 |
Propriétaire |
- INNER MONGOLIA KINGDOMWAY PHARMACEUTICAL CO., LTD. (Chine)
- XIAMEN KINGDOMWAY GROUP COMPANY (Chine)
- KINGDOMWAY BIOTECHNOLOGY (JIANGSU) CO., LTD. (Chine)
|
Inventeur(s) |
- Zhen, Ming
- Liu, Mengjing
- Wang, Li
- Liu, Qiyue
- Chen, Biqin
- Wang, Bingrong
- Li, Dan
- Wu, Yi
- Zhan, Guanghuang
|
Abrégé
The present disclosure provides a crystalline form of calcium D-glycerate of formula (I) and a method for preparing the crystalline form of calcium D-glycerate of formula (I). The crystalline form may be characterized by having X-ray powder diffraction pattern (XRPD) diffraction peaks (2θ degrees) at 12.9±0.2, 20.9±0.2, and 31.7±0.2.
Classes IPC ?
- C07C 59/10 - Acides polyhydroxycarboxyliques
- C07C 51/41 - Préparation de sels d'acides carboxyliques par conversion de ces acides ou de leurs sels en sels ayant la même partie acide carboxylique
- A61K 31/191 - Acides acycliques ayant plusieurs groupes hydroxyle, p. ex. acide gluconique
|
4.
|
10
Numéro d'application |
18343727 |
Numéro de brevet |
12221645 |
Statut |
Délivré - en vigueur |
Date de dépôt |
2023-06-28 |
Date de la première publication |
2024-01-04 |
Date d'octroi |
2025-02-11 |
Propriétaire |
- KINGDOMWAY BIOTECHNOLOGY (JIANGSU) CO., LTD. (Chine)
- INNER MONGOLIA KINGDOMWAY PHARMACEUTICAL CO., LTD. (Chine)
|
Inventeur(s) |
- Zhu, Jun
- Wang, Bingrong
- Xu, Fei
- Xing, Fei
- Li, Dan
|
Classes IPC ?
- C12P 7/66 - Préparation de composés organiques contenant de l'oxygène contenant la structure quinoïde
- C12N 9/02 - Oxydoréductases (1.), p. ex. luciférase
|
5.
|
METHODS FOR A CONTROLLED COENZYME Q10 FERMENTATION PRODUCTION PROCESS
Numéro d'application |
18171647 |
Statut |
En instance |
Date de dépôt |
2023-02-20 |
Date de la première publication |
2023-06-29 |
Propriétaire |
- INNER MONGOLIA KINGDOMWAY PHARMACEUTICAL CO., LTD. (Chine)
- XIAMEN KINGDOMWAY GROUP COMPANY (Chine)
|
Inventeur(s) |
- Zhan, Guanghuang
- Wu, Yi
- Chen, Biqin
- Zhu, Zhichun
- Li, Dan
|
Abrégé
Controlled coenzyme Q10 (CoQ10) fermentation production processes and methods for controlling the CoQ10 fermentation production processes are provided in the present disclosure. The processes may include growing a microbial culture of bacteria by providing a carbon source and an oxygen source for a predetermined period of time, thereby producing CoQ10-containing bacteria, carbon dioxide, and lactate in the bacterial culture. During various stages of the production process, the concentration of carbon dioxide may be maintained at predetermined levels, respectively. Alternatively or additionally, during various stages of the production process, the concentration of lactate may be maintained at predetermined levels, respectively.
|
6.
|
METHODS FOR A CONTROLLED COENZYME Q10 FERMENTATION PRODUCTION PROCESS
Numéro d'application |
18171650 |
Statut |
En instance |
Date de dépôt |
2023-02-20 |
Date de la première publication |
2023-06-29 |
Propriétaire |
- INNER MONGOLIA KINGDOMWAY PHARMACEUTICAL CO., LTD. (Chine)
- XIAMEN KINGDOMWAY GROUP COMPANY (Chine)
|
Inventeur(s) |
- Zhan, Guanghuang
- Wu, Yi
- Chen, Biqin
- Zhu, Zhichun
- Li, Dan
|
Abrégé
Controlled coenzyme Q10 (CoQ10) fermentation production processes and methods for controlling the CoQ10 fermentation production processes are provided in the present disclosure. The processes may include growing a microbial culture of bacteria by providing a carbon source and an oxygen source for a predetermined period of time, thereby producing CoQ10-containing bacteria, carbon dioxide, and lactate in the bacterial culture. During various stages of the production process, the concentration of carbon dioxide may be maintained at predetermined levels, respectively. Alternatively or additionally, during various stages of the production process, the concentration of lactate may be maintained at predetermined levels, respectively.
|
7.
|
Methods for a controlled coenzyme Q10 fermentation production process
Numéro d'application |
16599184 |
Numéro de brevet |
11584942 |
Statut |
Délivré - en vigueur |
Date de dépôt |
2019-10-11 |
Date de la première publication |
2020-11-12 |
Date d'octroi |
2023-02-21 |
Propriétaire |
- INNER MONGOLIA KINGDOMWAY PHARMACEUTICAL CO., LTD. (Chine)
- XIAMEN KINGDOMWAY GROUP COMPANY (Chine)
|
Inventeur(s) |
- Zhan, Guanghuang
- Wu, Yi
- Chen, Biqin
- Zhu, Zhichun
- Li, Dan
|
Abrégé
10-containing bacteria, carbon dioxide, and lactate in the bacterial culture. During various stages of the production process, the concentration of carbon dioxide may be maintained at predetermined levels, respectively. Alternatively or additionally, during various stages of the production process, the concentration of lactate may be maintained at predetermined levels, respectively.
|
8.
|
10 FERMENTATION PRODUCTION PROCESS
Numéro d'application |
CN2019085990 |
Numéro de publication |
2020/223923 |
Statut |
Délivré - en vigueur |
Date de dépôt |
2019-05-08 |
Date de publication |
2020-11-12 |
Propriétaire |
- INNER MONGOLIA KINGDOMWAY PHARMACEUTICAL CO., LTD. (Chine)
- XIAMEN KINGDOMWAY GROUP COMPANY (Chine)
|
Inventeur(s) |
- Zhan, Guanghuang
- Wu, Yi
- Chen, Biqin
- Zhu, Zhichun
- Li, Dan
|
Abrégé
1010101010-containing bacteria, carbon dioxide, and lactate in the bacterial culture. During various stages of the production process, the concentration of carbon dioxide may be maintained at predetermined levels, respectively. Alternatively or additionally, during various stages of the production process, the concentration of lactate may be maintained at predetermined levels, respectively.
Classes IPC ?
- C12P 7/66 - Préparation de composés organiques contenant de l'oxygène contenant la structure quinoïde
- C12R 1/01 - Bactéries ou actinomycètes
|
9.
|
Systems and methods for producing coenzyme Q10
Numéro d'application |
16690305 |
Numéro de brevet |
11773043 |
Statut |
Délivré - en vigueur |
Date de dépôt |
2019-11-21 |
Date de la première publication |
2020-03-19 |
Date d'octroi |
2023-10-03 |
Propriétaire |
- INNER MONGOLIA KINGDOMWAY PHARMACEUTICAL CO., LTD. (Chine)
- XIAMEN KINGDOMWAY GROUP COMPANY (Chine)
|
Inventeur(s) |
- Liao, Weicheng
- Wang, Bingrong
- Li, Dan
- Xu, Luming
- Jiang, Sifu
|
Abrégé
10-containing intermediate product.
|
10.
|
10
Numéro d'application |
CN2018098991 |
Numéro de publication |
2020/029017 |
Statut |
Délivré - en vigueur |
Date de dépôt |
2018-08-06 |
Date de publication |
2020-02-13 |
Propriétaire |
- INNER MONGOLIA KINGDOMWAY PHARMACEUTICAL CO., LTD. (Chine)
- XIAMEN KINGDOMWAY GROUP COMPANY (Chine)
|
Inventeur(s) |
- Liao, Weicheng
- Wang, Bingrong
- Li, Dan
- Xu, Luming
- Jiang, Sifu
|
Abrégé
10101010101010101010-containing intermediate product.
Classes IPC ?
- C07C 46/10 - SéparationPurificationStabilisationEmploi d'additifs
|
|